tiprankstipranks
Advertisement
Advertisement

AXSM Stock Latest News

Axsome Targets Smoking Cessation With New Phase 3 AXS-05 Trial
Company AnnouncementsAxsome Targets Smoking Cessation With New Phase 3 AXS-05 Trial
20h ago
AXSM
Axsome Therapeutics price target lowered to $297 from $304 at RBC Capital
PremiumThe Fly
Axsome Therapeutics price target lowered to $297 from $304 at RBC Capital
4d ago
AXSM
Analyst Reiterates Buy on Axsome, Sees Undervalued Pipeline Upside with Unchanged $310 Price Target
PremiumRatings
Analyst Reiterates Buy on Axsome, Sees Undervalued Pipeline Upside with Unchanged $310 Price Target
4d ago
AXSM
Axsome Therapeutics price target raised to $251 from $242 at Morgan Stanley
PremiumThe Fly
Axsome Therapeutics price target raised to $251 from $242 at Morgan Stanley
4d ago
AXSM
Axsome Therapeutics price target raised to $275 from $260 at Guggenheim
PremiumThe Fly
Axsome Therapeutics price target raised to $275 from $260 at Guggenheim
4d ago
AXSM
Axsome Therapeutics price target raised to $256 from $255 at Wells Fargo
PremiumThe FlyAxsome Therapeutics price target raised to $256 from $255 at Wells Fargo
4d ago
AXSM
Auvelity Momentum and Pipeline Progress Drive Undervalued Upside in Axsome, Supporting Buy Rating
Premium
Ratings
Auvelity Momentum and Pipeline Progress Drive Undervalued Upside in Axsome, Supporting Buy Rating
4d ago
AXSM
Myles Minter Reiterates Buy on Axsome as Auvelity Outperformance and AXS-12 NDA Acceptance Strengthen Long-Term Growth Outlook
Premium
Ratings
Myles Minter Reiterates Buy on Axsome as Auvelity Outperformance and AXS-12 NDA Acceptance Strengthen Long-Term Growth Outlook
5d ago
AXSM
Ami Fadia Reiterates Buy on Axsome as Auvelity Outperformance and Alzheimer’s Agitation Launch Momentum Offset Near-Term Margin Pressure
PremiumRatings
Ami Fadia Reiterates Buy on Axsome as Auvelity Outperformance and Alzheimer’s Agitation Launch Momentum Offset Near-Term Margin Pressure
5d ago
AXSM
Axsome reports strong Q2 revenue growth, expanding launches
PremiumCompany Announcements
Axsome reports strong Q2 revenue growth, expanding launches
5d ago
8K
AXSM
Axsome Therapeutics reports Q2 EPS (99c), consensus (85c)
PremiumThe Fly
Axsome Therapeutics reports Q2 EPS (99c), consensus (85c)
5d ago
AXSM
These Are the Stocks Reporting Earnings Today – August 10, 2026
PremiumMarket News
These Are the Stocks Reporting Earnings Today – August 10, 2026
5d ago
B
DJT
AXSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsAXSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7d ago
AXSM
Axsome Therapeutics price target lowered to $306 from $310 at Mizuho
Premium
The Fly
Axsome Therapeutics price target lowered to $306 from $310 at Mizuho
15d ago
AXSM
Axsome, Five Below, APPS, Intuit, Adobe Trending With Analysts
Premium
Weekend Updates
Axsome, Five Below, APPS, Intuit, Adobe Trending With Analysts
21d ago
ADBE
APPS
Axsome Advances AXS-14 Fibromyalgia Trial With New Long-Term Safety Update
PremiumCompany Announcements
Axsome Advances AXS-14 Fibromyalgia Trial With New Long-Term Safety Update
22d ago
AXSM
Axsome’s CLARITY Trial Targets Sleepy Depression: What Investors Should Watch
PremiumCompany Announcements
Axsome’s CLARITY Trial Targets Sleepy Depression: What Investors Should Watch
22d ago
AXSM
Axsome’s Phase 3 Fibromyalgia Trial of AXS-14 Takes Shape: What Investors Should Watch
PremiumCompany Announcements
Axsome’s Phase 3 Fibromyalgia Trial of AXS-14 Takes Shape: What Investors Should Watch
22d ago
AXSM
Shopify downgraded, Five Below upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Shopify downgraded, Five Below upgraded: Wall Street’s top analyst calls
25d ago
GS
RL
Axsome Therapeutics initiated with an Outperform at BMO Capital
PremiumThe FlyAxsome Therapeutics initiated with an Outperform at BMO Capital
26d ago
AXSM
Axsome Therapeutics initiated with an Outperform at BMO Capital
Premium
The Fly
Axsome Therapeutics initiated with an Outperform at BMO Capital
26d ago
AXSM
Axsome Therapeutics announces FDA acceptance of AXS-12 NDA
Premium
The Fly
Axsome Therapeutics announces FDA acceptance of AXS-12 NDA
1M ago
AXSM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >